| MR Imaging of Brain: Pharmacological Effects in Animals Hall C |
| 1274. Evaluation of Treatment Response to Yeast Cytosine Deaminase Gene Therapy with Diffusion MRI, L.D. Stegman, A. Rehemtulla, T.L. Chenevert and B.D. Ross, University of Michigan Medical School, Ann Arbor, MI, USA. |
| 1275. Contrast Enhanced Magnetic Resonance Imaging of Kainate Brain Injury, R. Frangez, M. Kosec, F. Demsar and K. Beravs, University of Ljubljana and Institute" Jozef Stefan", Ljubljana, Slovenia. |
| 1276. An Assessment of Soman-Induced Status Epilepticus, Y.A. Bhagat, A. Obenaus, M.G. Hamilton and E.J. Kendall, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. |
| 1277. Characterization of Cerebral Blood Flow during Anesthesia with Fentanyl, Isoflurane, or Pentobarbital in Normal Rats, K.S. Hendrich, P.M. Kochanek, J.A. Melick, K.D. Statler, D.S. Williams, D.W. Marion and C. Ho, Carnegie Mellon University and University of Pittsburgh, Pittsburgh, PA, USA. |
| 1278. Development of a Novel Neonatal in vivo Model of Neuronal Injury Relevant to Cerebral Ischemia, Using Ouabain, a Na+/K+-ATPase Inhibitor, W.B. Veldhuis, M. van der Stelt, G.A. Veldink, J.F.G. Vliegenthart, P.R. Bär and K. Nicolay, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands. |
| 1279. Measurement of Changes in CBF in MPTP-Treated and 7-NI Protected Rats Using FAIR Technique, Y-L. Pan, B-C. Shyu and C. Chang, Academia Sinica, Taipei, Taiwan, Republic of China. |
| 1280. Detection of Widespread Alterations in Brain Diffusion Following Focal Striatal Injection of the Inflammatory Cytokine TNF-a, N.R. Sibson, D.C. Anthony, A.M. Blamire, B. Rajagopalan, V.H. Perry and P. Styles, John Radcliffe Hospital and University of Oxford, Oxford, UK and University of Southampton, Southampton, UK. |
| 1281. Neuroprotective Effects of FK506 on Experimental Focal Ischemia Quantitatively Assessed by Diffusion-weighted MRI, T. Ebisu, K. Katsuta, A. Fujikawa, L. Aoki, M. Umeda, S. Naruse and C. Tanaka, Meiji College of Oriental Medicine and Kyoto Prefectural University of Medicine, Kyoto, Japan and Fujisawa Pharmaceutical Co., Ltd, Osaka, Japan. |
| 1282. Neuroprotection by Tetrahydrocannabinol in an in vivo Excitotoxicity-Model as Studied by Diffsion-Weighted and T2-Weighted MRI, M. van der Stelt, W.B. Veldhuis, P.R. Bär, G.A. Veldink, J.F.G. Vliegenthart and K. Nicolay, Utrecht University and University Medical Center Utrecht, The Netherlands. |